In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
As of close of business last night, Ionis Pharmaceuticals Inc’s stock clocked out at $38.49, down -1.71% from its previous closing price of $39.16. In other words, the price has decreased by -$1.71 from its previous closing price. On the day, 1.89 million shares were traded. IONS stock price reached its highest trading level at $39.29 during the session, while it also had its lowest trading level at $38.47.
Ratios:
To gain a deeper understanding of IONS’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 7.51 and its Current Ratio is at 7.61. In the meantime, Its Debt-to-Equity ratio is 7.50 whereas as Long-Term Debt/Eq ratio is at 7.33.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, BMO Capital Markets on August 02, 2024, Downgraded its rating to Market Perform and sets its target price to $60 from $67 previously.
On July 24, 2024, Leerink Partners Upgraded its rating to Outperform which previously was Market Perform and also upped its target price recommendation from $53 to $62.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Oct 16 ’24 when Swayze Eric sold 53 shares for $38.31 per share. The transaction valued at 2,031 led to the insider holds 157 shares of the business.
Geary Richard S sold 331 shares of IONS for $16,428 on Aug 29 ’24. The EVP, Chief Development Officer now owns 84,823 shares after completing the transaction at $49.63 per share. On Aug 28 ’24, another insider, Geary Richard S, who serves as the EVP, Chief Development Officer of the company, sold 320 shares for $49.16 each. As a result, the insider received 15,731 and left with 85,154 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, IONS now has a Market Capitalization of 6070297088 and an Enterprise Value of 5527912960. For the stock, the TTM Price-to-Sale (P/S) ratio is 7.46 while its Price-to-Book (P/B) ratio in mrq is 21.31. Its current Enterprise Value per Revenue stands at 6.796 whereas that against EBITDA is -16.717.
Stock Price History:
Over the past 52 weeks, IONS has reached a high of $54.44, while it has fallen to a 52-week low of $35.95. The 50-Day Moving Average of the stock is -11.25%, while the 200-Day Moving Average is calculated to be -13.65%.
Shares Statistics:
It appears that IONS traded 1.58M shares on average per day over the past three months and 1425720 shares per day over the past ten days. A total of 157.71M shares are outstanding, with a floating share count of 145.55M. Insiders hold about 7.71% of the company’s shares, while institutions hold 90.04% stake in the company. Shares short for IONS as of 1727654400 were 10533799 with a Short Ratio of 6.67, compared to 1724976000 on 10159853. Therefore, it implies a Short% of Shares Outstanding of 10533799 and a Short% of Float of 7.8.
